Article
Engineering a regulatable enzyme for homogeneous immunoassays.
Nature biotechnology - 1 Jan 1999
Legendre D, Soumillion P, Fastrez J
Abstract excerpt
We have engineered the phage displayed TEM-1 beta-lactamase to generate enzymes that can be used in homogeneous immunoassays because their activity can be modulated by binding to monoclonal antibodies (Mabs) raised against an unrelated protein. Random peptide libraries were genetically inserted into three loops to create hybrid enzymes with binding sites for Mabs. Insertion points were chosen to be close enough...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
